U.S. Department of Health and Human Services
Andrew Bremer

 Contact Info

Tel: 301-402-7886
Email: andrew.bremer@nih.gov

 Select Experience

  • Associate ProfessorMedicine and Pediatrics, Vanderbilt University2010-2013
  • Clinical FellowPediatric Endocrinology, University of California, San Francisco2005-2007
  • ResidencyInternal Medicine / Pediatrics, Baylor College of Medicine2001-2005
  • M.A.S.Clinical Research, University of California, Davis2007-2009
  • M.D., Ph.D.Boston University2001

Andrew Bremer, M.D., Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities & Activities

My portfolios include clinical studies in (1) gestational diabetes and maternal outcomes, and (2) HIV/AIDS-associated metabolic and endocrine dysfunction. I am also the Project Scientist and/or Program Official on several large NIDDK-supported multi-center clinical trials involving both children and adults with type 1 and type 2 diabetes, including those testing the long-term safety and efficacy of artificial pancreas device systems.

​Research Programs

Clinical Research in Type 2 Diabetes
This program supports studies in humans aimed at the prevention, treatment, and diagnosis of type 2 diabetes across the lifespan, as well as further characterizing and understanding the mechanistic aspects of the etiology of type 2 diabetes

Diabetes and Metabolism HIV/AIDS
The Diabetes and Metabolism HIV/AIDS program supports studies on the metabolic complications of HIV infection and treatment, including endocrine and body composition abnormalities

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of type 1 and type 2 diabetes

Obesity, Pregnancy, and the Intrauterine Environment
This program supports basic and clinical research to understand the effects of over-nutrition, obesity, and diabetes on pregnant women and the metabolic health of their offspring

Pathophysiology of Diabetes and Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology of metabolic diseases, including the etiology of type 1 diabetes and other autoimmune endocrine diseases

Current Committee Memberships

  • NIDDK Clinical Studies Working GroupMember
  • NIDDK Obesity Working GroupMember